Faxes? Really? AI system speeds up new patient process
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Jan-2026 14:11 ET (1-Jan-2026 19:11 GMT/UTC)
World-leading experts have launched an online platform to enable the public to shape the future of bowel cancer research and patient care.
ASHG will host the Genetic Diagnosis & Rare Disease Virtual Symposium on December 2–3, featuring 16 expert-led sessions on cutting-edge genomic technologies and rare disease diagnosis. The event offers interactive learning, up to six CME credits, and global access to innovations like long-read sequencing, RNA-Seq, and federated variant sharing.
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes COVID-19, and how viral mutations weaken that attachment. The findings, published in the November 21 online issue of Cell Systems, a Cell Press journal, explain why variants like Omicron can evade immune defenses and suggest new strategies for building longer-lasting antibody therapies and vaccines. The team analyzed more than a thousand three-dimensional structures of antibodies bound to the virus’s spike protein, the main target for immune recognition, and compiled them into a structural atlas of COVID-19 antibodies. By studying these structures together for the first time, the researchers revealed a detailed picture of how the immune system targets the virus and how the virus evolves to evade it.